HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The efficacy of gallium scintigraphy in detecting malignant soft tissue neoplasms.

Abstract
A prospective study was conducted on 55 consecutive patients to evaluate the efficacy of gallium scintigraphy in detecting malignancy in any soft tissue mass. It was determined that gallium scintigraphy could detect malignancy with a sensitivity of 96% and a specificity of 87%. Large and small sarcomas, irrespective of their fascial location, were identifiable by gallium imaging. Occult, nonpulmonary sites of disseminated disease were detected in 13%. Gallium scintigraphy proved to be a reliable predictor of malignancy for all soft tissue masses, but because of its cost, it must be used judiciously.
AuthorsH S Schwartz, C K Jones
JournalAnnals of surgery (Ann Surg) Vol. 215 Issue 1 Pg. 78-82 (Jan 1992) ISSN: 0003-4932 [Print] United States
PMID1731652 (Publication Type: Journal Article)
Chemical References
  • Gallium Radioisotopes
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Evaluation Studies as Topic
  • False Negative Reactions
  • False Positive Reactions
  • Female
  • Gallium Radioisotopes (administration & dosage)
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging (methods)
  • Prospective Studies
  • Radionuclide Imaging (methods)
  • Sarcoma (diagnostic imaging, pathology)
  • Sensitivity and Specificity
  • Soft Tissue Neoplasms (diagnostic imaging, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: